[1]
K. NM Al-Khero, “Effect of tyrosine kinase inhibitor in patients with chronic myeloid leukemia (cytogenetic, molecular response) in Mosul”, Ann. coll. Med. Mosul , vol. 40, no. 2, pp. 1–8, Dec. 2018.